Literature DB >> 7750737

Export of Bordetella pertussis serotype 2 and 3 fimbrial subunits by Escherichia coli.

C A Guzmàn1, G Piatti, L H Staendner, F Biavasco, C Pruzzo.   

Abstract

Bordetella pertussis serotype 2 and 3 fimbrial subunits were expressed and exported in Escherichia coli using the recently described expression/secretion vector pCGV1. Two protease deficient E. coli strains (CAG629 and EC538) and two periplasmic-leaky mutants (AE84064 and A593) were transformed with the different constructs and, after thermal induction, proteins present in the various cellular compartments were analyzed by Western blot. The results obtained with the two types of fimbrial subunits were generally the same: a recombinant protein of the expected molecular mass (19.2 kDa) was present in the periplasm of the leaky mutants and of CAG629 strain (Ion protease- and heat shock protease-deficient). Only the expression of the recombinant fimbrial subunits by the tolB A593 mutant resulted in protein release into the extracellular medium. These results indicate that the use of hybrid plasmids based on pCGV1 in combination with the tolB mutant constitute an efficient system for the export of recombinant proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750737     DOI: 10.1111/j.1574-6968.1995.tb07521.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  2 in total

1.  One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100.

Authors:  J Yang; T Moyana; S MacKenzie; Q Xia; J Xiang
Journal:  Appl Environ Microbiol       Date:  1998-08       Impact factor: 4.792

2.  Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides.

Authors:  Marylise Duperthuy; Annika E Sjöström; Dharmesh Sabharwal; Fatemeh Damghani; Bernt Eric Uhlin; Sun Nyunt Wai
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.